262 related articles for article (PubMed ID: 1966585)
1. Hypophysectomy and injections of high doses of estrogens inhibit the growth of ovary-independent rat mammary carcinomas.
Nomura S; Yoshida H; Kaneko Y
In Vivo; 1990; 4(2):121-5. PubMed ID: 1966585
[TBL] [Abstract][Full Text] [Related]
2. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors.
Yoshida H; Fukuhara T; Yamashi S; Yoshida A; Fukunishi R; Tsuji M; Matsumoto K
Cancer Res; 1983 May; 43(5):2311-6. PubMed ID: 6403234
[TBL] [Abstract][Full Text] [Related]
3. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
[TBL] [Abstract][Full Text] [Related]
4. Establishment of pharmacological doses of estrogen-dependent mammary tumors with estrogen and progesterone receptors.
Yoshida H; Yoshida A; Noguchi S; Matsumoto K
In Vivo; 1987; 1(3):157-61. PubMed ID: 2979780
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a slow-growing, transplantable rat mammary tumor (MCR-83): a model for endocrine-related cell kinetic studies.
van Dierendonck JH; Cornelisse CJ; van der Linden PW; van Putten LM; van de Velde CJ
Cancer Res; 1987 Aug; 47(15):4093-8. PubMed ID: 3607751
[TBL] [Abstract][Full Text] [Related]
6. Independent regulation of growth and steroid receptors in uterus and mammary tumors of rats.
Janssens JP; Billiet G; Bonte J; De Loecker W
Anticancer Res; 1983; 3(6):385-91. PubMed ID: 6230984
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
8. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
9. Biological characteristics and estrogen and progesterone receptors in mammary carcinoma induced in male Sprague-Dawley rats by a series of intragastric intubations of 7,12-dimethylbenz(a)anthracene.
Yoshida H; Yoshida A; Fukunishi R; Sato B; Okamoto S; Matsumoto K
Cancer Res; 1982 Jun; 42(6):2434-9. PubMed ID: 6804090
[TBL] [Abstract][Full Text] [Related]
10. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
Ip MM; Milholland RJ; Rosen F; Kim U
Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
[TBL] [Abstract][Full Text] [Related]
11. Regression with secretory changes of ovary-independent rat mammary carcinoma by pharmacological doses of estrogen.
Yoshida H; Yoshida A; Yamada M; Yamanaka K; Kitamura Y; Matsumoto K
Jpn J Cancer Res; 1985 Aug; 76(8):771-8. PubMed ID: 3930454
[TBL] [Abstract][Full Text] [Related]
12. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
Zanardi S; De Menech R; Pino G; Guarneri D; Dandolo G; Sanguineti M; Moro MG; Barbi GP; Paganuzzi M; Boccardo F
Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642
[TBL] [Abstract][Full Text] [Related]
13. Additional effects of medroxyprogesterone acetate on mammary tumors in oophorectomized, estrogenized, DMBA-treated rats.
Sakamoto S; Kudo H; Suzuki S; Mitamura T; Sassa S; Kuwa K; Chun Z; Yoshimura S; Maemura M; Nakayama T; Shinoda H
Anticancer Res; 1997; 17(6D):4583-7. PubMed ID: 9494572
[TBL] [Abstract][Full Text] [Related]
14. [The status of steroid receptors and hormone response in 7,12-dimethylbenz (a) anthracene (DMBA) induced rat mammary tumor].
Zhang HY; Liu MS; Wang XM; Li SH; Hu C
Shi Yan Sheng Wu Xue Bao; 1985 Jun; 18(2):225-30. PubMed ID: 3012916
[No Abstract] [Full Text] [Related]
15. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
Sylvester PW; Ip C; Ip MM
Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
[TBL] [Abstract][Full Text] [Related]
16. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
Tominaga T; Yoshida Y; Kitamura M; Kosaki G
Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
18. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Bodwin JS; Clair T; Cho-Chung YS
Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of progesterone and tamoxifen in estrogen-induced mammary carcinogenesis in ovariectomized W/Fu rats.
Inoh A; Kamiya K; Fujii Y; Yokoro K
Jpn J Cancer Res; 1985 Aug; 76(8):699-704. PubMed ID: 3930447
[TBL] [Abstract][Full Text] [Related]
20. Effects of sequential and combined endocrine therapies on the growth of 7,12-dimethylbenz [alpha] anthracene-induced rat mammary carcinoma.
Iino Y; Ogawa T; Yoshida M; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1990 Sep; 20(3):259-62. PubMed ID: 2147726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]